Magnetic Resonance Imaging as an Alternative to <scp>Contrast‐Enhanced</scp> Computed Tomography to Mitigate Iodinated Contrast Shortages in the United States: Recommendations From the International Society for Magnetic Resonance in Medicine

Scott B. Reeder, Christopher P. Hess, Greg Zaharchuk, Linda Moy, on behalf of the IsmrmJournal of Magnetic Resonance Imaging 2022 · DOI · OpenAlex

Abstract

On April 19, 2022, the United States (US) Contrast Media Division of GE Healthcare released a letter reporting an acute shortage of iohexol (Omnipaque), the most widely used iodinated contrast media used for contrast-enhanced computed tomography (CE-CT) and CT angiography (CTA) in the United States. The unexpected dearth of iodinated contrast media in the United States came as the result of disruptions in the production of iohexol at GE Healthcare's Shanghai plant due to a series of local lockdowns from the COVID-19 pandemic. Although GE Healthcare has indicated that they expect the shortage to subside by late June 2023, there is currently a national crisis in the timely access for CE-CT and CTA. As various mitigation strategies are implemented by healthcare systems to increase supply and decrease utilization of CT contrast, the current “contrast crisis” brings to light new supply chain vulnerabilities in the delivery of imaging services and highlights the need to develop alternative imaging pathways for patient care. Mitigation strategies include the use of noncontrast CT, postponing CT exams for nonemergent indications, the substitution of alternative imaging modalities such as magnetic resonance imaging (MRI) and angiography (MRA), ultrasound, or nuclear scintigraphy, and off-label use of gadolinium-based contrast agent (GBCA)-enhanced CT.1, 2 In this editorial, we emphasize how MRI is an appropriate, timely, and cost-effective substitute for CE-CT for many clinical indications. Where possible, the ISMRM also recommends the use of abbreviated or “focused” protocols to minimize the overall MRI exam time and mitigate the additional burden on MRI service to maintain access for all patients with clinically indicated MRI.10 Focused MRI protocols performed in under 10 minutes are a powerful tool to reduce MRI exam time and improve access in general, not just those for whom CT was initially considered. Focused MRI protocols can direct urgent patient management in the emergency or inpatient setting and to manage treatment decisions in the outpatient setting. The application of focused MRI protocols has been described for a variety of neurological imaging applications,3, 4 pulmonary MRA,7 aortic MRA,5 MRI for appendicitis,8 and even HCC screening/surveillance.9 Focused MRI protocols are an effective means to provide a high level of diagnostic information, very similar to and in many cases superior to CT, particularly when using dynamic CE T1-weighted MRI. Importantly, the ISMRM recommends the use of MRI protocols to replace CT only when there is sufficient evidence within the literature and/or appropriateness criteria to indicate the use of MR as a diagnostic tool. While MRI is a flexible and a highly diagnostic imaging technique capable of clinical applications such as the examples provided above, it may not be suitable for all indications. Other imaging modalities such as ultrasound (including contrast-enhanced ultrasound) and nuclear scintigraphy may be more appropriate depending on the local expertise and access to MRI. The specific use of MRI protocols in emergency situations depends on access to MRI from the emergency department. This depends on local practice and may be appropriate, if available. However, in some settings, the use of MRI to mitigate iodinated contrast shortages may be limited to outpatient imaging only. While the cost of MRI is often marginally higher than for analogous CT studies, the use of diagnostic-related group metrics for reimbursement may enable easier access to MRI in this setting. Another factor is that for many disorders, particularly within the brain and spine, CE-CT lacks the required sensitivity, such that follow-up MRI studies are often ordered as part of the patient workup even following CT scanning. As such, starting with MRI may actually reduce the overall cost of care. Finally, it is essential that any workflow used to enhance access to MRI must adhere to safety protocols, and include rapid, efficient, and effective screening to identify individual patients with contraindications to MRI. In summary, the current shortage of iodinated contrast media for CT/CTA is a challenging situation that will require a multifaceted approach to mitigate its impact on patient care. Alternative imaging modalities including MRI/MRA should play a contributory role to serve our patients and maintain the availability of iodinated contrast for those applications that require CE-CT or CTA. Special considerations should be given to the use of focused MRI protocols for all patients undergoing MRI, to shorten protocols and maintain access to MRI in general.
BibTeX
@article{reeder2022magnetic,
  author = {Scott B. Reeder and Christopher P. Hess and Greg Zaharchuk and Linda Moy and on behalf of the ISMRM},
  title = {{Magnetic Resonance Imaging as an Alternative to <scp>Contrast‐Enhanced</scp> Computed Tomography to Mitigate Iodinated Contrast Shortages in the United States: Recommendations From the International Society for Magnetic Resonance in Medicine}},
  journal = {Journal of Magnetic Resonance Imaging},
  year = {2022},
  doi = {10.1002/jmri.28282},
}

Loading related content...

Figure